CGRP Receptor Antagonist a Promising New Migraine Abortive Drug
Calcitonin gene-related peptide (CGRP) receptor antagonist MK-0974 holds promise as a migraine abortive, according to Phase II study results that will be presented at the American Headache Society‘s annual meeting this week. The drug works by blocking CGRP, a brain chemical that is important for…